Skip to main content

Market Overview

Global Clinical In-Vitro Diagnostic Medical Laboratory Services Market Report 2021: Clinical Labs Under Pressure as COVID-19 Pandemic Closes Healthcare Operations

Share:

Dublin, March 02, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market - Strategy & Trends, Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country: Updated with Impact of COVID-19 - 2021 to 2025" report has been added to ResearchAndMarkets.com's offering.

The Clinical Laboratory has seen steady growth for the last 20 years, but this is changing with the effect of the COVID pandemic on healthcare and economic activity. Worse still, Point of Care and Self Testing are threatening long term demand. Understand the opportunities and the threats in this comprehensive report.

The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report. A range of dynamic trends are pushing market growth and company valuations.

Exciting technical developments, especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

The report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2021 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

Key Trends:

  • The genetic blizzard
  • Emerging economies and global prosperity
  • Pharmacogenomics
  • Healthcare expansion in China
  • Climate change
  • Globalization
  • Automation

Key Topics Covered:

Clinical Laboratory Services - Strategic Situation Analysis and Impact Analysis of COVID Recession

  • Guide for Executives, Marketing, Sales and Business Development Staff
  • Guide for Management Consultants and Investment Advisors

1. Introduction and Market Definition
1.1 The Growing Demand for Clinical Testing
1.2 Defining the Opportunity
1.2.1 Volumes
1.2.2 Prices
1.2.3 Revenue Market Size
1.3 Methods and Sources
1.3.1 Authors
1.3.2 Sources
1.4 U.S. Medical Market and laboratory Testing - Perspective
1.4.1 U.S. Medicare Expenditures for Laboratory Testing

2. Overview of a Dynamic Market
2.1 Market Players - Roles & Impacts
2.1.1 Supplier/pharmaceutical
2.1.2 Independent lab specialized/esoteric
2.1.3 Independent lab national/regional
2.1.4 Independent lab analytical
2.1.5 Public National/regional lab
2.1.6 Hospital lab
2.1.7 Physician lab
2.1.8 Audit body
2.2 Segmentation - Different Approaches
2.2.1 Traditional Market Segmentation
2.2.2 Laboratory Focus and Segmentation
2.3 Structure of Clinical Testing Industry
2.3.1 The Hospital Lab - Share of the Pie
2.3.2 Key Role for Economies of Scale
2.3.3 Physician Office Lab's are Still Here
2.3.4 Physician's and POCT - Reviving Patient Service in China
2.4 National and Regional Diversity

3. Trends Driving a Changing Market
3.1 Growth Is Pushed from Many Sides
3.1.1 Understanding the Impact of Aging Population.
3.1.2 COVID Related Testing Growth
3.1.3 Point of Care Testing can increase demand
3.1.4 Alternative Medicine Creates Testing Opportunity
3.1.5 Esoteric Testing Moving Mainstream
3.1.6 Genetic Based Testing Creates New Department and New Discipline
3.2 Factors at Work to Shrink The Market
3.2.1 COVID 19 Recession
3.2.2 Economic or population contraction.
3.2.3 Testing usage analysis curtailing growth
3.2.4 Wellness has a downside
3.2.5 Test Displacement Impacts Important
3.2.6 Point of Care Testing
3.3 Automation
3.3.1 Stranded LIMS Investment
3.3.2 Software as a Service
3.3.3 Physician Office and Access Systems
3.4 Environment and Evolution
3.5 Diagnostic Technology Development
3.5.1 Next Generation Sequencing Fuels a Revolution
3.5.2 Impact of NGS on pricing
3.5.3 POCT/Self Testing Disruptive Force
3.5.4 Pharmacogenomics Blurs Diagnosis and Treatment
3.5.5 CGES Testing, A Brave New World
3.5.6 Molecular Diagnostics Technologies at The Forefront of Growth
3.5.7 Biochips/Giant magneto resistance based assay

4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments
4.1 Recent Developments - Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section

  • Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay
  • FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations
  • Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
  • Cooperative Aims to Expand Clinical, Commercial NGS Access
  • Emerging COVID-19 Sequencing Assays - An Alternative to Existing Diagnostics?
  • CDC Ranks Two More Microbes as 'Urgent Threat'
  • ACLA Requests $5 billion to keep private labs going
  • Applied Biology to Launch New Laboratory for Hair and Skin Disorders
  • Quest Diagnostics Acquires Outreach Operations
  • Quest Diagnostics Buys Assets of Boston Clinical Laboratory Services
  • CLA Urges FDA to Halt Crackdown on PGx Testing
  • Quest Diagnostics Subsidiary Buys True Health Dx Assets
  • BioReference Laboratories selected by IPA Association
  • Predictive Laboratories Announces Research Collaboration
  • NEOMED-LABS / Pacific Biomarkers Acquires PAIRimmune Francais
  • LabCorp and Envigo Complete Transactions
  • PathGroup Acquires Pathologists Bio-Medical Laboratories
  • Predictive Technology Acquires Taueret Laboratories
  • Quest Diagnostics Acquires Laboratory Services Business of Boyce & Bynum Pathology
  • Laboratories
  • Gestalt Diagnostics Expands Market Reach with Peak Medical Acquisition
  • Amazon exploring consumer health diagnostics
  • Quest Diagnostics Acquires Laboratory Services Operation in Central Michigan
  • NeoGenomics to acquire Genoptix, Inc
  • Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec
  • Charles River Labs to acquire contract research firm for $800M
  • GROUPE BIO7 to be Sold to CERBA HEALTHCARE
  • GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform

5. Profiles of Key Companies

  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Adicon Clinical Laboratories
  • American Bio-Clinical Laboratories, Int'l
  • American Pathology Partners
  • ARUP Laboratories
  • Ascend Clinical
  • Aurora Diagnostics
  • Bio-Reference Laboratories
  • Bioscientia Institut fur Medizinische Diagnostik GmbH
  • BP Healthcare Group
  • Clinical Reference Laboratory
  • Clongen Laboratories
  • CompuNet Clinical Laboratories
  • Diagnosticos da America
  • DIAN Diagnostics Co., Ltd
  • Enzo Life Sciences, Inc
  • Eurofins Scientific
  • Exagen Diagnostics
  • Genomic Health
  • Genzyme Corporation
  • Gribbles Pathology
  • Guangzhou Kingmed Diagnostics Group Co., Ltd
  • Integrated Regional Laboratories
  • KDL Group
  • Laboratory Corporation of America
  • Lifelabs
  • Mayo Clinic Laboratories
  • Mid America Clinical Laboratories
  • Myriad Genetics/Myriad RBM
  • NeoGenomics
  • Pathology, Inc.
  • Psychemedics Corporation
  • Quest Diagnostics
  • RDL Reference Laboratory
  • Sonic Healthcare
  • Spectra Laboratories
  • Synlab Group
  • Unilabs

6. The Global Market for Clinical Laboratory Testing
6.1 Global Market Overview by Country
6.2 Global Market by Assay Type - Overview

7. Global Clinical Laboratory Diagnostic Markets - By Assay Type
7.1 Chemistry
7.2 Microbiology
7.3 Hematology
7.4 Anatomic Pathology
7.5 Covid-19
7.6 Molecular Diagnostics

8. Global Clinical Laboratory Diagnostic Markets - Price and Volume Charts
8.1 Chemistry Price and Volume
8.2 Microbiology Price and Volume
8.3 Hematology Price and Volume
8.4 Anatomic Pathology Price and Volume
8.5 Covid-19 Price and Volume
8.6 Molecular Diagnostics Price and Volume

9. The Future of the Clinical Laboratory

For more information about this report visit https://www.researchandmarkets.com/r/d1u4b6


CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Primary Logo

View Comments and Join the Discussion!
 

Latest Ratings

StockFirmActionPT
GTMorgan StanleyDowngrades
BPHSBCUpgrades
UBAPiper SandlerUpgrades22.0
MPCRaymond JamesUpgrades69.0
JKSUBSUpgrades41.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com